Caspian Journal of Internal Medicine
Babol University of Medical Sciences
شنبه 4 اسفند 1403
[Archive]
دوره 15، شماره 4 - ( 6-1403 )
جلد 15 شماره 4 صفحات 728-713 |
برگشت به فهرست نسخه ها
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Bozorgmehr R, Esmaili Tarki F, Yazdi E, Shahrokhi Nejad S. COVID-19 associated lung cavitary lesions: A case series. Caspian J Intern Med 2024; 15 (4) :713-728
URL: http://caspjim.com/article-1-4050-fa.html
URL: http://caspjim.com/article-1-4050-fa.html
COVID-19 associated lung cavitary lesions: A case series. . 1403; 15 (4) :713-728
چکیده: (639 مشاهده)
Background: Our study discusses the probable etiologies and characteristics of pulmonary cavities in post-COVID-19 patients. A pulmonary cavity is a late complication of the disease, yet it has led to multiple referrals to our tertiary hospital in Tehran, Iran.
Methods: We conducted a retrospective case-series study on 20 patients who were admitted to our center between April 2020 and September 2021. They were all diagnosed with COVID-19 and concomitantly developed pulmonary cavities. We assessed their electronic medical records in 2021 and compared their characteristics with other studies based on the available literature.
Result: Of the 20 patients with cavities, 12 (60%) had been diagnosed with prior COVID-19, and 9 (45%) had type 2 diabetes mellitus. 9 patients (45%) had bacterial superinfections while 4 (44%) had fungal infections. All patients received corticosteroids, but only 4 (20%) were additionally administered Tocilizumab.
Conclusion: COVID-19 patients can develop pulmonary cavities during recovery; however, this infrequent radiologic finding depends on specific risk factors.
Methods: We conducted a retrospective case-series study on 20 patients who were admitted to our center between April 2020 and September 2021. They were all diagnosed with COVID-19 and concomitantly developed pulmonary cavities. We assessed their electronic medical records in 2021 and compared their characteristics with other studies based on the available literature.
Result: Of the 20 patients with cavities, 12 (60%) had been diagnosed with prior COVID-19, and 9 (45%) had type 2 diabetes mellitus. 9 patients (45%) had bacterial superinfections while 4 (44%) had fungal infections. All patients received corticosteroids, but only 4 (20%) were additionally administered Tocilizumab.
Conclusion: COVID-19 patients can develop pulmonary cavities during recovery; however, this infrequent radiologic finding depends on specific risk factors.
نوع مطالعه: Case Series |
موضوع مقاله:
Pulmonology
دریافت: 1402/5/23 | پذیرش: 1402/8/16 | انتشار: 1403/6/8
دریافت: 1402/5/23 | پذیرش: 1402/8/16 | انتشار: 1403/6/8
| بازنشر اطلاعات | |
 |
این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است. |
